OptimizeRx Corporation (OPRX): Price and Financial Metrics

OptimizeRx Corporation (OPRX): $10.94

0.06 (-0.55%)

POWR Rating

Component Grades








Add OPRX to Watchlist
Sign Up

Industry: Internet - Services




#26 of 28

in industry

OPRX Price/Volume Stats

Current price $10.94 52-week high $16.65
Prev. close $11.00 52-week low $6.92
Day low $10.74 Volume 52,202
Day high $11.00 Avg. volume 130,608
50-day MA $11.05 Dividend yield N/A
200-day MA $11.33 Market Cap 199.87M

OPRX Stock Price Chart Interactive Chart >

OptimizeRx Corporation (OPRX) Company Bio

OptimizeRx Corporation operates an Internet website through which it offers advice to consumers on how to save money on branded prescription and over-the-counter healthcare products.

OPRX Latest News Stream

Event/Time News Detail
Loading, please wait...

OPRX Latest Social Stream

Loading social stream, please wait...

View Full OPRX Social Stream

Latest OPRX News From Around the Web

Below are the latest news stories about OPTIMIZERX CORP that investors may wish to consider to help them evaluate OPRX as an investment opportunity.

Should You Exit OptimizeRx Corp. (OPRX)?

Wasatch Global Investors, an investment management firm, released its “Wasatch Micro Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark during the quarter. The quality-oriented positioning was the main reason for the strategy’s outperformance in the quarter. In addition, please check the fund’s […]

Yahoo | December 26, 2023

OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco

WALTHAM, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that executives from the Company will be presenting and participating in one-on-ones at the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA from January 8-11, 2024. The OptimizeRx presentation will take

Yahoo | December 18, 2023

OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?

OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | December 11, 2023

With 74% institutional ownership, OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst the big guns

Key Insights Given the large stake in the stock by institutions, OptimizeRx's stock price might be vulnerable to their...

Yahoo | December 11, 2023

Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should Know

The consensus price target hints at a 41.3% upside potential for OptimizeRx Corp. (OPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | December 6, 2023

Read More 'OPRX' Stories Here

OPRX Price Returns

1-mo -13.79%
3-mo -13.17%
6-mo -22.02%
1-year -27.02%
3-year -78.99%
5-year -29.28%
YTD -23.55%
2023 -14.82%
2022 -72.95%
2021 99.33%
2020 203.41%
2019 -6.38%

Continue Researching OPRX

Here are a few links from around the web to help you further your research on OptimizeRx Corp's stock as an investment opportunity:

OptimizeRx Corp (OPRX) Stock Price | Nasdaq
OptimizeRx Corp (OPRX) Stock Quote, History and News - Yahoo Finance
OptimizeRx Corp (OPRX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!